SEB Asset Management AB

Source: SEC Form 13F · as of Mar 2026

SEB Asset Management AB holds 67 biotech & pharma companies tracked by BioSniper, totaling $3.98B in value as of Mar 2026 (SEC Form 13F).

Companies held

67

Total value held

$3.98B

CompanySharesValue
AZNASTRAZENECA PLC5,954,417$1.16B
LLYELI LILLY & Co387,272$356.2M
JNJJOHNSON & JOHNSON1,286,484$314.5M
BMYBRISTOL MYERS SQUIBB CO3,586,365$217.5M
ABBVAbbVie Inc.946,326$205.8M
MRKMerck & Co., Inc.1,642,285$197.6M
GMOptec International, Inc.2,307,277$171.9M
GILDGILEAD SCIENCES, INC.1,233,000$171.8M
CORCencora Inc.427,004$134.1M
MCKMcKesson Corporation149,949$129.8M
UNHUnitedHealth Group Incorporated Common Stock (DE)298,761$80.8M
AMGNAMGEN INC180,676$63.6M
VRTXVERTEX PHARMACEUTICALS INC / MA140,951$62.9M
INCYIncyte Corp.646,168$60.8M
TEVATeva Pharmaceutical Industries Limited1,977,137$59.6M
ABTABBOTT LABORATORIES492,081$50.5M
IQVIQVIA Holdings Inc.228,726$39.0M
PFEPFIZER INC1,332,170$37.4M
DGXQuest Diagnostics Incorporated139,951$27.4M
INSMINSMED Inc165,576$27.1M
PTGXProtagonist Therapeutics, Inc232,416$24.5M
IDXXIDEXX LABORATORIES INC /DE36,527$20.5M
IBRXImmunityBio, Inc.2,447,150$18.8M
BNTXBioNTech SE200,108$17.8M
BBIOBridgeBio Pharma, Inc.235,813$17.5M
REGNREGENERON PHARMACEUTICALS, INC.21,697$16.8M
ONCBeOne Medicines Ltd.56,078$16.7M
BMRNBIOMARIN PHARMACEUTICAL INC293,277$16.6M
CAHCardinal Health Inc.78,004$16.5M
ELVElevance Health Inc.47,580$13.9M
RPRXRoyalty Pharma plc270,309$13.0M
KRYSKrystal Biotech, Inc.46,343$12.0M
GPCRStructure Therapeutics Inc.245,043$11.8M
ZTSZoetis Inc.88,974$10.5M
UTHRUNITED THERAPEUTICS Corp17,731$10.5M
NBIXNEUROCRINE BIOSCIENCES INC79,577$10.5M
ALNYALNYLAM PHARMACEUTICALS, INC.30,153$10.0M
ARWRARROWHEAD PHARMACEUTICALS, INC.158,205$9.9M
JAZZJazz Pharmaceuticals plc46,362$8.8M
NAMSNEWAMSTERDAM PHARMA CO N.V.272,654$8.7M
IONSIONIS PHARMACEUTICALS INC114,334$8.6M
UPBUpstream Bio, Inc.878,473$7.9M
CRNXCrinetics Pharmaceuticals, Inc.213,891$7.8M
ALHCAlignment Healthcare Inc.438,537$7.7M
BIIBBIOGEN INC.41,869$7.7M
KALVKalVista Pharmaceuticals, Inc.351,305$7.1M
RVMDREVOLUTION MEDICINES, INC.69,630$6.8M
EWTXEdgewise Therapeutics, Inc.206,512$6.5M
MOHMolina Healthcare Inc48,505$6.5M
GEHCGE HealthCare Technologies Inc.89,796$6.4M
COGTCogent Biosciences, Inc.164,437$6.3M
SLNOSOLENO THERAPEUTICS INC187,475$6.3M
OSCROscar Health Inc.503,534$5.8M
CPRXCATALYST PHARMACEUTICALS, INC.224,705$5.6M
OLMAOlema Pharmaceuticals, Inc.339,461$5.1M
ZBHZimmer Biomet Holdings Inc.39,524$3.6M
WSTWest Pharmaceutical Services Inc.13,478$3.4M
CRVSCorvus Pharmaceuticals, Inc.226,837$3.3M
ZBIOZenas BioPharma, Inc.163,860$3.2M
VRDNViridian Therapeutics, Inc.\DE156,957$3.1M
ANIPANI PHARMACEUTICALS INC38,114$2.9M
HALOHALOZYME THERAPEUTICS, INC.34,700$2.2M
PGNYProgyny Inc.76,500$1.3M
ABCLAbCellera Biologics Inc.340,267$1.2M
HRMYHarmony Biosciences Holdings, Inc.40,532$1.1M
DVADaVita Inc.4,279$658K
OGNOrganon & Co.35,107$210K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    SEB Asset Management AB — Biotech 13F Holdings & Portfolio | BioSniper